Daly James M
CIK 0001560782
Director
Filings
22
Latest Jun 1, 2026
Issuers covered
5
Showing
22 of 22
Page 1
Track record
22 of 22 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 22 | 95% | +11.4% | +13.0% | +17.7% | -20.8% |
| 90 days | 22 | 23% | -4.3% | -9.2% | +19.3% | -14.2% |
| 180 days | 22 | 86% | +9.5% | +17.0% | +19.3% | -26.5% |
| 365 days | 21 | 0% | -30.0% | -27.7% | -26.7% | -36.9% |
Issuers
Companies where Daly James M has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 6 | Jun 1, 2026 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 6 | Jun 24, 2025 |
| CYTK | Cytokinetics Inc | 4 | May 27, 2026 |
| BLCM | Bellicum Pharmaceuticals, Inc | 3 | Jan 5, 2023 |
| HALO | Halozyme Therapeutics, Inc. | 3 | Aug 15, 2023 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|